EMEA-000049-PIP01-07-M03
Key facts
| Invented name |
Plavix
|
| Active substance |
clopidogrel
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/233/2010
|
| PIP number |
EMEA-000049-PIP01-07-M03
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Prevention of thromboembolic events
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Sanofi Pharma Bristol-Myers Squibb SNC
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000049-PIP01-07-M03
|
| Compliance opinion date |
10/12/2010
|
| Compliance outcome |
positive
|